@FierceMedDev: CMO adds 200 medical device jobs in Ireland. Report | Follow @FierceMedDev
@MarkHFierce: A new FMD feature--this week in FDA med tech violations, the device industry's police blotter. More | Follow @MarkHFierce
@DamianFierce: Abbott won the FDA's OK for a diagnostic that detects birth defects and testicular cancer progress. News | Follow @DamianFierce
> SynapDx, developer of an autism blood test, has secured an undisclosed but "significant" investment from the Kraft Group, owner of the New England Patriots and other companies. Article
> Thermo Fisher ($TMO) has partnered with the University of Birmingham to develop mass spectrometry diagnostic technologies. More
> GE Healthcare ($GE) won FDA clearance for two new MR scanners the company says outperform and cost less than previous generations. Release
> March has been a rough month for dealmaking, as global M&A stumbled to its lowest rate in three years. Story
> Life Technologies ($LIFE) is investing $18 million to expand its molecular diagnostics facility in Pleasanton, CA. Item
> The FDA has applied its most serious label to Vascular Solutions' hemostasis valves, warning that a malfunction could lead to dangerous air embolisms in patients. Note
> Engineers at Caltech have teamed with Israel's LeukoDx to develop a portable device that can count white blood cells from anywhere, potentially helping patients with diseases like leukemia avoid repeat hospital visits. More
Biotech News
@FierceBiotech: From FierceBiotechResearch.com: New drug could combat resistant #malaria strains. Story | Follow @FierceBiotech
@JohnCFierce: 3 yrs after its first CRL, AP Pharma gets another. Insists it can do a quick turnaround, but wrong again on FDA: News | Follow @JohnCFierce
@RyanMFierce: With big RNA deal, AstraZeneca's Soriot signals yen for risky science. More | Follow @RyanMFierce
> Connecticut pols stunned as Pfizer brings in the wrecking ball. Item
> Repros shares boom on promising PhIII results for testosterone drug. Report
> Biogen Idec rolls up FDA OK for blockbuster multiple sclerosis drug Tecfidera. News
Pharma News
@FiercePharma: Conquering the complexities of biologics to get to biosimilars. Special report | Follow @FiercePharma
@EricPFierce: Alexion files 8-K saying FDA is not impressed with its manufacturing at its Rhode Island plant. 8-K filing | Follow @EricPFierce
> Rose-colored glasses off for many of 2012's new drugs, report shows. More
> Drugstores push for access to secret PBM pricing-and-reimbursement info. Story
Vaccines News
> GSK vaccine plant helps U.S. arm for biodefense. Report
> Taboo topics: Sex, politics, religion... and vaccines? Article
> Swedish study adds to data linking GSK vax to narcolepsy. Item
> FDA moves decision day for GSK pandemic vaccine, but why? More
Pharma Manufacturing News
> Alexion gets warning letter for Soliris plant. Report
> FDA lifts ban on some Aurobindo antibiotics. News
> Injection point: BD, Teva, Hikma target sterile injectables. Story
> GSK gets OK for $91M vaccine plant with Texas A&M. Article